Stop The Clot: Shytasia’s Journey Toward Healing and Advocacy
The National Blood Clot Alliance (NBCA) recently posted a touching story on X:
”Shytasia was at work when she experienced sensory impairment. At the hospital, her symptoms were initially dismissed. Now, Shytasia is focused on healing, self-advocacy, and living every moment with purpose. Stop The Clot.”
Read more stories from NBCA Stop The Clot journal here.
Shytasia was at work when she suddenly experienced unexpected sensory impairment—a concerning symptom that led her to seek urgent medical attention.
However, upon arriving at the hospital, her symptoms were initially dismissed, a reality too many patients face when early warning signs of serious conditions are overlooked.
Thanks to NBCA Shytasia joined support groups, and today, she is channeling her experience into a mission of self-advocacy, awareness, and healing.
Her story underscores the importance of listening to patients, recognizing atypical presentations, and ensuring that no concern is minimized—especially when it comes to blood clot-related disorders.

Find the rest of the story in gallery.
More stories from hemostasis disorders community featured in Hemostasis Today.
-
Feb 27, 2026, 18:30Sanjeev Saksena: From Isolated Case Reports to Clinical Evidence for Post-Ablation Myocardial Ischemia
-
Feb 27, 2026, 18:21Priya Prasad: Can Money Buy Blood?
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:19Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?
-
Feb 27, 2026, 18:14Mohamed Sikkander Abdul Razak: Factor XIa Inhibitors Show Promise With Lower Bleeding Risk
-
Feb 27, 2026, 18:09Hariom Rajput: Early Recognition and Prevention of Deep Vein Thrombosis
-
Feb 27, 2026, 18:08Karen Fahey: What If the Blood Products You Rely On Weren’t Safe?
-
Feb 27, 2026, 17:46Perla Bandini: Whole-Exome Sequencing Unveils Suspected Primary Hemostasis Disorders
-
Feb 27, 2026, 17:44Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia